GlassScriptPhysician profile
Kenny Oh
NPI 1871080184
$6,834.41
in general payments reported to CMS, 2019-2025
19 companies · $948 in 2025
The $948 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $2,736 · 2024: $3,150 · 2025: $948.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,126 · Travel and Lodging: $2,510 · Education: $199.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,125.94 |
| Travel and Lodging | $2,509.59 |
| Education | $198.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $2,013.34 | 2024-2025 | Oasis, Pico, Allevyn Gentle Border 10 X 10cm Ctn 10 |
| Medtronic, INC. | $1,315.49 | 2023-2024 | Turbohawk, Endurant Iis |
| W. L. Gore & Associates, INC. | $1,010.95 | 2023-2025 | Excluder Conformable Aaa Endoprosthesis With Active Control, Gore Viabahn Vbx Balloon Expandable Endo, Gore Excluder Thoracoabdominal Branch Endoprosthesis |
| Inari Medical, INC. | $835.97 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Boston Scientific Corporation | $258.83 | 2023-2025 | Axios, Athletis, Coyote Es |
| Endologix LLC | $251.99 | 2024-2025 | Alto Abdominal Stent Graft System, Afx2 Bifurcated Endograft System |
| Silk Road Medical, INC. | $219.82 | 2023-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Acera Surgical, INC. | $208.38 | 2024 | Restrata Wound Matrix |
| Lemaitre Vascular, INC. | $183.03 | 2023-2025 | Artegraft Vascular Graft |
| Organogenesis INC. | $171.66 | 2024 | Puraply Franchise |
| Next Science LLC | $86.73 | 2024 | Xperience, Surgx, Blastx |
| Lifenet Health | $76.93 | 2025 | Theragenesis Wound Matrix |
| Solventum Corporation | $48.28 | 2024-2025 | Activ.A.C. |
| Shockwave Medical, INC | $39.85 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Mimedx Group, INC. | $33.14 | 2025 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $30.72 | 2024 | Coseal |
| Urgo Medical North America, LLC | $19.47 | 2024 | Urgoclean Ag |
| Paladin Technology Solutions | $15.01 | 2025 | |
| Kerecis Limited | $14.82 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenny Oh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.